Geriatric Oncology Articles

Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study

2021-07-29T22:37:51+02:00

Westley T, Syrowatka A, Henault D, Rho YS, Khazoom F, Chang SL, Tamblyn R, Mayo N, Meguerditchian AN. J Geriatr Oncol. 2018 May;9(3):204-213. doi: 10.1016/j.jgo.2017.10.003. Epub 2017 Nov 28.

Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study2021-07-29T22:37:51+02:00

What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper

2021-07-29T22:37:52+02:00

Loh KP, Soto-Perez-de-Celis E, Hsu T, de Glas NA, Battisti NML, Baldini C, Rodrigues M, Lichtman SM, Wildiers H. J Oncol Pract. 2018 Feb;14(2):85-94. doi: 10.1200/JOP.2017.026435.

What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper2021-07-29T22:37:52+02:00

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group

2021-07-29T22:37:52+02:00

Wildiers H, Tryfonidis K, Dal Lago L, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Altintas S, Touati N, Cardoso F, Brain E. Lancet Oncol. 2018 Mar;19(3):323-336. doi: 10.1016/S1470-2045(18)30083-4. Epub 2018 Feb 9.

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group2021-07-29T22:37:52+02:00
Go to Top